Stocklytics Platform
Asset logo for symbol ABEO
Abeona Therapeutics
ABEO59
$5.580.00%$0.00
Asset logo for symbol ABEO
ABEO59

$5.58

0.00%

AI Deep-Learning Forecast (ABEO)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Abeona Therapeutics (ABEO) Stocklytics Forecast

Abeona Therapeutics Inc (ABEO) is a biopharmaceutical company that focuses on developing gene and cell therapies for rare genetic diseases. The company's stock price has been a subject of interest for investors and analysts, with many trying to predict its future performance. While it is challenging to accurately forecast stock prices, there are various factors that can influence ABEO's stock price in the coming years.
One important aspect to consider is the progress of Abeona Therapeutics' pipeline. The company is currently developing several potential therapies for rare diseases like Sanfilippo syndrome, EB-101 for recessive dystrophic epidermolysis bullosa, and ABO-202 for CLN1 disease. Positive results from clinical trials and regulatory approvals can significantly impact the stock price in a positive way. Conversely, setbacks in clinical trials or regulatory challenges may negatively affect the stock.
add Abeona Therapeutics  to watchlist

Keep an eye on Abeona Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Abeona Therapeutics (ABEO) stock?

Analysts have set a target price of $18.73 for Abeona Therapeutics (ABEO), based on forecasts from 15 analysts. The predicted price range extends from a high of $40 to a low of $1. This represents a potential increase of up to 616.85% and a decrease of -82.08% from the current price of $5.58. These forecasts are as of 2017 Oct 12.
help

What are the analyst ratings for Abeona Therapeutics (ABEO) stock?

The analyst ratings for Abeona Therapeutics (ABEO) are distributed as follows: 8 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering Abeona Therapeutics .
help

What is the AI price prediction for Abeona Therapeutics (ABEO) stock?

The AI price prediction model, leveraging machine-learning techniques, forecasts that Abeona Therapeutics (ABEO) stock could reach $5.67 by 2024 Sep 30. This prediction indicates a potential price change of 1.59%. The forecast has a lifetime of 30 days, culminating on the target date provided. The prediction was made on 2024 Sep 09.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media